Iovance Biotherapeutics, Inc. Common Stock (IOVA) is a publicly traded Healthcare sector company. As of July 30, 2026, IOVA trades at $4.68 with a market cap of $2.10B and a P/E ratio of -2.49. IOVA moved +1.54% today. Year to date, IOVA is +67.03%; over the trailing twelve months it is +56.16%. Its 52-week range spans $1.64 to $9.30. Analyst consensus is strong buy with an average price target of $9.80. Rallies surfaces IOVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest IOVA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.68 |
| Market Cap | $2.10B |
| P/E Ratio | -2.49 |
| EPS | $-1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.30 |
| 52-Week Low | $1.64 |
| Volume | 921.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19M |
| Net Income | $-444.04M |
| Gross Margin | -804.54% |
5 analysts cover IOVA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.80.